Chaosu Hu

机构：Shanghai Medical College of Fudan University, Central South University, Fudan University Shanghai Cancer Center, Second Xiangya Hospital of Central South University · ORCID：0000-0001-6407-3311

发表论文 144 篇 · 总被引 1986 次 · h-index 15

代表论文

• Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study (2024 · Signal Transduction and Targeted Therapy · 被引 19)
• Abstract CT011: Penpulimab versus placebo in combination with chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A global, multicenter, randomized, double-blind, phase 3 trial (AK105-304) (2025 · Cancer Research · 被引 7)
• Delta magnetic resonance imaging radiomics features‑based nomogram predicts long‑term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma (2024 · Oral Oncology · 被引 7)
• Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study (2026 · Signal Transduction and Targeted Therapy · 被引 4)
• Impact of age stratification on risk of lymph node metastasis in T1 oral tongue squamous cell carcinomas patients (2024 · American Journal of Otolaryngology · 被引 3)
• A phase II umbrella clinical trial of advanced salivary gland cancer based on molecular typing. (2024 · Journal of Clinical Oncology · 被引 3)